Background. Surface-associated fibronectin (Fn)-binding proteins of Streptococcus pyogenes play an important role in the bacterial invasion of epithelial cells. We examined the functional domain and protective antigenicity of the Fn-binding protein FbaA.
or skin, after which the bacteria circulate in the bloodstream and spread to other organs. During this process, specific and nonspecific interactions between bacterial surface molecules and epithelial-cell receptors are mediated in serum by extracellular matrix proteins such as fibronectin (Fn) [1] . Fn-binding proteins located on the bacterial surface play an important role in the invasion of epithelial cells [2] . Furthermore, Fn-binding proteins of S. pyogenes-including F1 [2] /SfbI [3] , F2 [4] , SfbII [5] , FBP54 [6] , PFBP [7] , Fba (renamed FbaA) [8] , and FbaB [9] -have been identified, and they are thought to function as adhesins and invasins.
Many surface proteins of gram-positive cocci exhibit striking similarities in the amino acid sequence of the C-terminal region, which is a unique, well-conserved sequence termed the "LPXTG motif" [10, 11] . Several genome sequence projects of S. pyogenes have been completed and published on the World Wide Web (see the DNA Data Bank of Japan, available at: http://gib .genes.nig.ac.jp/). Using the genome sequence of S. py- ogenes strain SF370 (serotype M1), we found 9 open-reading frames that contained the LPXTG motif. One of these was designated fbaA and was found to be located downstream of the scpA gene, which is located on the 3 end of the mga regulon, a multiple-gene regulator of S. pyogenes [8] . Pandiripally et al. [12] reported that FbaA in plasma binds to factor H (FH) and FH-like protein 1 (FLH-1), which promote an accelerated decay of C3 convertase and work as cofactors in factor 1-mediated cleavage of C3b to inactivated C3b. Binding of FbaA to FH and FLH-1 has been found to significantly enhance bacterial survival in vitro [12, 13] , and the data suggested that Fn-binding protein FbaA has antiopsonin and antiphagocytic functions. Serotype M1 strains are most frequently isolated from patients with severe invasive infections [14] [15] [16] . It has been reported that, among the Fn-binding proteins, FbaA and FBP54 are expressed on the surface of M1 strains [8] . FbaA also contributes to the survival of S. pyogenes in the infected host by binding with human FH and FLH-1. In the present study, we constructed a series of recombinant (r) glutathione S-transferase (GST)-truncated FbaA proteins to further investigate the mechanisms of Fn binding and localization on the surface of S. pyogenes. In addition, we analyzed whether FbaA could serve as a vaccine candidate against S. pyogenes infection.
MATERIALS AND METHODS
Bacterial strains, plasmids, and mice. The bacterial strains and plasmids used in the study are listed in table 1. S. pyogenes strains were grown in Todd-Hewitt broth (Difco Laboratories) supplemented with 0.2% yeast extract (THY). For antibiotic selection, kanamycin (300 mg/mL) was added to THY medium. Escherichia coli was grown in Luria-Bertani (LB) broth (Sigma) or on LB agar plates. Antibiotics were used at the following concentrations: 100 mg/mL for ampicillin and 30 mg/mL for kanamycin. All mice were purchased from Charles River Laboratories Japan and were treated throughout the experiments in accordance with our institutional guidelines.
DNA procedures. Purification of chromosomal DNA from S. pyogenes and electroporation of S. pyogenes to construct fbaAdeficient mutants were performed as described elsewhere [17] . Plasmid DNA preparation, transformation of E. coli, and polymerase chain reaction (PCR) were performed as described elsewhere [18] . DNA sequences were determined with a BigDye Terminator Ready Reaction kit (version 3.1; Applied Biosystems) and an ABI Prism 310 genetic analyzer (Applied Biosystems).
Construction and purification of rFbaA. DNA fragments encoding each FbaA domain ( figure 1A ) were amplified by PCR from chromosomal DNA of strain SSI-9 (serotype M1) with their specific primer pairs ( figure 1A and table 2) . The resul- tant PCR products were ligated into an expression vector, pGEX-6P-1 (Amersham Biosciences). rGST-FbaA proteins were obtained from E. coli BL21 that contained the appropriate plasmids. After induction with isopropyl-b-d-1-thiogalactopyranoside, the recombinant proteins were purified with a glutathione Sepharose 4B affinity column (Amersham Biosciences), in accordance with the manufacturer's instructions. Rabbit antiserum was prepared as described elsewhere [19] . Ligand-blotting analysis using biotinylated Fn was performed as described elsewhere [8, 20] .
Biomolecular interaction analysis. Biacore analysis was performed as described elsewhere [21] . Fn (Invitrogen) or bovine serum albumin (BSA; Sigma) was diluted and adjusted to a concentration of 100 mg/mL in 10 mmol/L of sodium acetate (pH 4.0). Then it was applied to the surface of a Sensor Chip CM5 (Biacore International). rFbaA was dialyzed against HBSP buffer (10 mmol/L HEPES, 150 mmol/L NaCl, 3.4 mmol/L EDTA, and 0.005% Tween 20 [pH 7.4] ) and injected at a flow rate of 30 mL/min at 25ЊC. The concentration of FbaA was adjusted to 125, 250, 500, and 1000 nmol/L. S. pyogenes strains were also resuspended in HBSP buffer at a concentration of ∼ cfu/mL and analyzed at a flow rate of 20 mL/min 10 1.0 ϫ 10 at 25ЊC. Fn-binding activity was presented, after the deduction of BSA-binding activity, as resonance units on the sensorgram.
Immunization and challenge. BALB/c mice were anesthetized with pentobarbital and subcutaneously immunized with 2 mmol of recombinant protein in Freund's complete or incomplete adjuvants (Difco Laboratories), and serum was collected on days 0, 14, 28, and 42, as described elsewhere [19] . S. pyogenes strains were grown at 37ЊC to an OD 600 of 0.4 and washed twice with sterile PBS. They were then resuspended in sterile PBS, and the suspensions were adjusted to concentrations of 1 ϫ 10 6 -1 ϫ 10 8 cfu/mL. Mice were anesthetized and injected intraperitoneally with a suspension of 0.1 mL of S. pyogenes. Mouse mortality was monitored every 24 h for 2 weeks.
ELISA. For measuring FbaA-specific IgG in serum, an NOTE. Chromosomal DNA from group A streptococci was digested with EcoRI and subjected to Southern-hybridization analysis. The fbaA gene was used as a probe. The no. of strains examined is shown in parentheses. The no. of repeats was determined by DNA sequencing using an ABI PRISM model 310.
ELISA was performed as described elsewhere [22] . To determine IgG antibody concentrations in serum, 10 mg/mL of sheep antimouse IgG antibody (Nordic Immunology) was coated onto microtiter plates (Sumitomo Bakelite). After blocking with PBS that contained skim milk, a calibration curve was obtained by use of 2-fold serial dilutions of mouse IgG (Southern Biotechnology Associates) as the standard. The diluted IgG antibodies were added to plates and incubated for 1 h at 37ЊC. Then, after washing with PBS-Tween 20, horseradish peroxidase-conjugated goat anti-mouse IgG (Southern Biotechnology Associates) was added to the wells. After incubation with 3,3 ,5,5 -tetramethylbenzidine solution (Moss) for 15 min, the reactions were stopped by the addition of 0.5 mol/L HCl. Optical densities were measured at 450 nm using a microplate reader (Titertek MK 11; Flow Laboratories). The resultant optical densities were plotted on a graph and fitted to a linear equation for the calibration curve using the CA-Cricket Graph III program (version 1.53; Computer Associates International).
Bactericidal assay. In vitro whole-blood bactericidal assays were performed with a modified version of the bactericidal test of Lancefield [23] , as described elsewhere [19] . S. pyogenes strain SSI-9 (serotype M1) was cultured until the midlogarithmic phase and adjusted with PBS to a concentration of 1 ϫ 10 3 -5 ϫ 10 3 cfu/mL. Eighty microliters of healthy human whole blood was heparinized and mixed with 20 mL of rabbit antiFbaA IgG (final concentration, 200 mg/mL). Anti-FbaA IgG was purified with a MAbTrap Kit (Amersham Biosciences), in accordance with the manufacturer's instructions. Then, 100 mL of test antiserum was incubated with 20 mL of bacterial suspension. After a 3-h rotation at 37ЊC, aliquots were plated on THY agar plates, and the colonies were counted.
Cell culture and epithelial-cell adherence/invasion assays. HEp-2 human laryngeal epithelial cells (ATCC CCL23) were cultured in Dulbecco's modified Eagle medium (DMEM; Sigma) supplemented with 10% fetal bovine serum (Invitrogen) at 37ЊC in an atmosphere that contained 5% CO 2 and 95% air. HEp-2 cells were grown in a 24-well plate (р cells/well) 4 5 ϫ 10 and infected with 1 ϫ 10 6 -5 ϫ 10 6 cfu/well of S. pyogenes strain SSI-9 supplemented with human Fn (5 mg/mL) for 2 h. Before infection, the bacterial suspension was incubated with DMEM that contained 10% rabbit anti-FbaA serum for 30 min. To determine the level of bacterial adhesion, infected cells were washed 3 times with DMEM and lysed with 1 mL of sterile distilled water. To measure bacterial invasion, the culture medium was replaced with DMEM that contained gentamicin (100 mg/mL) and penicillin (100 U/mL). After a 1-h incubation at 37ЊC, the cells were washed 3 times and dispersed with 1 mL of distilled water. The number of bacterial colony-forming units was determined by plating a serial lysate dilution on THY agar.
Statistical analysis. The significance of differences between the means of the groups was evaluated using a nonparametric Mann-Whitney U test. For the results presented in figures 4 and 5, statistical analysis of mouse mortality was performed by Fisher's exact probability test. All tests were analyzed using StatView J software (version 5.0; SAS Institute).
RESULTS
Identification of the functional domain of FbaA. Each fragment of FbaA was expressed as a GST-fusion protein and purified using affinity-column chromatography ( figure 1A and  1B) . The Fn-binding domain of FbaA was analyzed by ligand blotting. Fragments A2-A5, which contain the repeat domain (RD), demonstrated Fn-binding activity ( figure 1C ). Because the RD of FbaA is highly homologous to the Fn-binding protein FnBPA of Staphylococcus aureus [8] , the result was expected. However, biotinylated Fn failed to recognize the immobilized N-terminal (fragment A1) and C-terminal (fragment A6) regions. To examine the distribution of the fbaA gene and number of repeats among various emm genotype strains, we sequenced the PCR products of fbaA using specific primers (table 2). The distribution and numbers of repeats were nearly totally conserved among the particular emm genotypes (table 3) . Real-time profiles of Fn binding of FbaA. Ligand-blotting approaches revealed a specific interaction between immobilized RD and soluble Fn ( figure 1C) . To determine the affinities of the interactions between the soluble FbaA domains and Fn, Figure 3 . Localization of FbaA domains on Streptococcus pyogenes cell surfaces. Each domain was displayed by immunofluorescence staining. Cultured S. pyogenes organisms were washed with PBS and then blocked with human IgG (50 mg/mL) and goat IgG (50 mg/mL). FbaA was visualized with rabbit anti-FbaA serum and Alexa Fluor 594-conjugated goat anti-rabbit IgG (red images), and S. pyogenes was stained with SYBR Green II (green images). Stained structures on S. pyogenes were observed using a confocal laser scanning microscope (Zeiss LSM 510). A, Rabbit anti-A1 serum (N terminus). B, Rabbit anti-A4 serum (repeat domain). C, Rabbit anti-A6 serum (C terminus). D, Rabbit preimmune serum, which was used as a negative control. direct surface plasmon resonance was measured using the biomolecular interactions monitoring system BiacoreX. As is shown in figure 2A , fragments A2, A3, A4, and A5, which contain RD, bound to immobilized Fn with a high rate of association and a low rate of dissociation. The bound proteins reacted rapidly with Fn and were released slowly from Fn. However, fragments A1 and A6 did not bind to Fn. When the affinities between Fn and intact FbaA on wild-type S. pyogenes and fbaA-deficient mutant strains were examined, the FbaA-expressing strains were found to have high affinities to Fn, compared with the FbaA-lacking mutants ( figure 2B-2D) .
Localization of functional domains of FbaA on S. pyogenes. Because the ligand-blotting and Biacore analyses revealed that rRD was associated with Fn, we considered that it was important to determine whether RD was exposed on the bacterial surface. To analyze the localization of RD, we prepared specific antisera for each domain of FbaA and used immunofluorescent microscopy (figure 3). S. pyogenes was observed as a green image by SYBR Green II, and each domain of FbaA was visualized with specific antiserum. Alexa Fluor 594-conjugated secondary antibody was shown as a red image. The N terminus and RD were exposed externally, which suggests that RD serves as a Fn-binding element on live organisms ( figure  3A and 3B) .
FbaA-specific antibody responses after component immunization. To determine whether each domain could raise protective antibodies against a lethal S. pyogenes challenge, 5 groups of mice were each immunized with GST-truncated FbaA proteins or with only GST as a negative control. Mice were immunized on days 0, 14, 28, and 42. Before each vaccination, serum was collected, and the specific responses to FbaA were measured by ELISA. Antibody responses to FbaA were elicited in all of the FbaA-immunized groups (figure 4). Notably, specific antibodies were induced efficiently in groups of mice immunized with fragments A1 and A3 ( ), whereas mice P ! .05 immunized with fragment A4 showed unexpectedly lower antibody titers. The N terminus in fragments A1 and A3 had the most hydrophobic region in FbaA. These results indicate that the N-terminal region A1 has the best immunogenicity among the 3 regions (A1, A4, and A6) in the FbaA protein.
Protection and antibody responses. Approximately 70%-80% of mice immunized with GST alone or with fragment A6 died within 2 days after S. pyogenes challenge, whereas all mice vaccinated with fragments A3 and A4 survived after the challenge (figure 5A). Vaccination with fragment A1 conferred 75% protection against S. pyogenes challenge. Next, we challenged mice with heterologous serotype M strains with or without FbaA, to determine whether FbaA-specific antibodies would capture FbaA on the cell surface in vivo. Mice immunized with fragment A3 survived for significantly longer periods, compared with GST-immunized mice, after challenge with a serotype M1 (FbaA positive) strain. Mice challenged with a serotype M3 or M12 (FbaA negative) strain showed mortality equal to that of GST-immunized mice ( figure 5B and 5C ). Similar results were obtained in replicate experiments. These data suggest that the antibodies raised in immunized mice recognized an FbaA protein on the bacterial surface and contributed to protection against FbaA-expressing S. pyogenes infection.
Bactericidal activity of FbaA antiserum. Figure 5A shows that the mice immunized with each GST-truncated FbaA protein acquired various levels of protection against S. pyogenes infection. Therefore, we hypothesized that a number of immunological epitopes are present in the N terminus and RD that might induce a protective immune response. To evaluate the phagocytotic ability of each induced antibody, rabbit antiFbaA antibodies against fragments A1 (N terminus), A3 (whole), A4 (RD), and A6 (C terminus) were used in bactericidal tests. Antibodies against fragments A1, A3, A4, and protein M1 (as a positive control) were found to be bactericidal against S. pyogenes strain SSI-9 (serotype M1, FbaA positive), whereas anti-fragment A6 and preimmune antibodies did not reduce the number of colony-forming units of S. pyogenes (table 4) . The results of vaccination with FbaA in mice (figure 5A) were consistent with those of the bactericidal assays, in that protection against S. pyogenes challenge in vivo was correlated with the presence of bactericidal epitopes in FbaA protein.
Inhibition of adhesion and invasion by FbaA antiserum. Bacterial adhesion to and intracellular invasion of epithelial cells by S. pyogenes is dependent on the presence of serum, plasma Fn, or laminin and Fn-binding proteins [2, 8, 19] . To determine the localization the invasion-related domains in FbaA, we as sayed several truncated FbaA antiserum samples for their inhibition of internalization by FbaA-expressing S. pyogenes. Antiserum to the entire length of FbaA (fragment A3) and RD (fragment A4) significantly inhibited bacterial adhesion and invasion. However, antiserum against the N and C terminals (fragments A1 and A6) did not (figure 6). These results suggest 8.7 ϫ 10 7.4 ϫ 10 * , ** (fusion protein-immunized groups vs. GST-immunized group, Fisher's exact probability test).
that RD is essential for cell adhesion and invasion of serotype M1 S. pyogenes.
DISCUSSION
In recent years, significant progress has been reported in the identification and characterization of S. pyogenes surface proteins that promote adhesion to and invasion of host epithelial cells. The interaction of S. pyogenes with epithelial cells is critical for the initiation of severe infectious diseases, and surface Fnbinding proteins on bacteria are important virulence factors involved in adhesion to Fn-rich epithelial cells. It has also been demonstrated that immobilized Fn-binding proteins are able to bind to soluble Fn and Fn and to form a bridge between bacterial Fn-binding protein F1 and host a 5 b 1 integrin [24] . Previous studies have shown that the Fn-binding protein of S. pyogenes, FbaA, is a major virulence determinant located on the bacterial surface [8, 12, 13] . Because invasive streptococcal diseases are initiated by the colonization of host cells [8, 9] , we speculated that interruption as an initial step would be effective in protecting against S. pyogenes infection. In the present study, we constructed a series of rGST-truncated FbaA proteins to investigate the mechanisms of Fn binding and localization on the surface of S. pyogenes. In addition, we attempted to determine whether the FbaA region could serve as a vaccine candidate against S. pyogenes infection.
Several strategies have been proposed for the development of a vaccine against S. pyogenes. Most studies have focused on the surface M protein, which is a major virulence factor that contains strong epitopes and induces type-specific protective antibodies in human serum after infection [25] . As is shown in table 4, anti-M1 antibody efficiently promoted phagocytosis in a bactericidal test. However, it is problematic for M protein to function as a vaccine, because it possesses some epitopes that cross-react with human tissues [26] . In contrast, there have Figure 6 . Effects of rabbit anti-truncated FbaA serum on bacterial adhesion to and invasion of human epithelial cells. Streptococcus pyogenes strain SSI-9 was suspended in Dulbecco's modified Eagle medium that contained 10% rabbit antiserum reactive to the indicated proteins and that was used to infect HEp-2 cell monolayers. Preimmune serum was added as a negative control. Then a standard assay procedure was performed [8] . The experiments were conducted 3 times, and representative data are presented. The percentage of adhesion or invasion was calculated as (colonyforming units of adhesion or invasion/colony-forming units of the . Data are expressed as the means of the percentage of S. pyogenes inoculum) ϫ 100 recovered per well for 6 independent determinations ‫ע‬ SEs. * (vs. preimmune serum, Mann-Whitney U-test). P ! .05 been no reports that Fn-binding proteins have harmful autoimmune epitopes, as do M proteins [27] .
Our selection of an Fn-binding protein for S. pyogenes as a vaccine candidate was based on the results of epidemiologic studies of invasive diseases and historical information linking certain serotypes to STSS [14] [15] [16] . Specific serotypes, such as M1, have been identified as being highly virulent and invasive. Of the Fn-binding proteins, FbaA and FBP54 are expressed on the surface of serotype M1 strains; therefore, we studied FbaA as a vaccine candidate for infection with serotype M1 strains [8, 28] . Guzmán et al. [29] stated that another Fn-binding protein, SfbI, may be a good vaccine candidate against S. pyogenes; however, it is not expressed on serotype M1 strains. Furthermore, a recent study reported that a complex of SfbI, a homologue of protein F1, and plasma Fn down-regulated S. pyogenes virulence by limiting bacterial spread into deep-tissue infections [30] . However, the results of some studies supported our selection of FbaA for use as a vaccine candidate. Pandiripally et al. [12] demonstrated that FbaA contributes to bacterial escape from the host immune system and enhances its virulence by using a function other than Fn binding. Furthermore, they claimed that FbaA could attenuate C3b deposition on the bacterial surface through the binding of FH and FLH-1 in a human complement system [12, 13] .
We constructed a series of GST-truncated recombinant FbaA proteins to investigate the mechanisms of Fn binding and localization on the bacterial cell surface. Ligand-blotting and Biacore analyses revealed that FbaA has a Fn-binding region that consists of a 3-5-proline-rich RD. Immunofluorescent microscopy findings showed that the N terminus and RD on the bacterial cell surface were recognized by anti-truncated FbaA serum. Mice were immunized with a series of truncated proteins to determine which domain was essential for the production of antibodies specific for S. pyogenes, and specific antibody responses were induced in all GST-truncated FbaA immunized groups. In addition, the N terminus-and RD-immunized mice were protected against challenge with a lethal dose of S. pyogenes. These results demonstrate that RD may function by means of Fn-binding on live organisms and that RD and the hydrophobic N-terminal region in FbaA have good immunogenicity.
These findings are also supported by our results from the bacterial adhesion/invasion assays that used anti-truncated FbaA antisera in vitro ( figure 6 and table 4) , whereas an ELI-SA revealed that the induction of antigen-specific antibodies was not adequate in mice immunized with the N terminus or RD, compared with that in mice immunized with the entire FbaA protein (figure 4). We speculated that the immune response against RD was not raised efficiently from a quantitative point of view; however, it might interfere with bacterial colonization ( figure 6 ) and the spread into deep tissues by an Fn-binding protein. The hydrophobic N terminus could also induce a high level of bactericidal antibody, although the antibody did not interrupt Fn-dependent intracellular invasion (figure 6 and table 4). Therefore, both the N terminus and RD may be required to induce a sufficient protective response against lethal infection by S. pyogenes. However, the C terminus was not exposed externally, which suggests that the region did not serve as an epitope on live organisms ( figure 3C ). Furthermore, when mice were infected with a serotype M49 (FbaA positive) strain, they showed moderate survival ( figure 5D ). As is shown in table 4, immunization with rFbaA (serotype M1) induced a moderate level of bactericidal antibodies against the serotype M49 strain. These findings might have been due to differences in sequence between the serotype M1 and M49 strains. The homologies of each FbaA domain between strain SSI-9 (serotype M1) and strain CS101 (serotype M49) were determined to be as follows: A1 (74%), A3 (58%), A4 (52%), and A6 (79%).
More than 100 types of M protein have been described, and all Fn-binding proteins are distributed in a particular group of M serotypes [4, 8, 28, 31] . It is possible that serotype M1 strains of S. pyogenes are among the strongest pathogenic types; however, there are also other highly virulent serotypes [32] [33] [34] [35] . As is shown in figure 5B and 5C, FbaA-immunized mice did not survive after challenge with FbaA-negative S. pyogenes serotypes. Serotype M3 and M12 strains possess the Fn-binding proteins FbaB and SfbI, respectively; however, those proteins have only low levels of homology to FbaA (!15%), whereas SfbI/protein F1 has been found in ∼70% of clinically isolated strains that belong to various M serotypes [27, 36] . If a mixture of SfbI and FbaA was used in a divalent S. pyogenes vaccine, the vaccine content might be able to overlap with the proteins in most serotypes that cause invasive or uncomplicated infections. Our results show that FbaA is a promising vaccine candidate for infection with serotype M1 strains and may be effective against the most prevalent and virulent serotypes.
